S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
QQQ   296.28 (+0.61%)
AAPL   116.03 (+0.75%)
MSFT   213.87 (+0.00%)
FB   275.59 (-0.48%)
GOOGL   1,764.13 (+0.01%)
AMZN   3,185.07 (+2.15%)
TSLA   574.00 (+3.35%)
NVDA   529.39 (+2.14%)
BABA   277.72 (-0.80%)
CGC   26.87 (-0.37%)
GE   10.50 (+0.48%)
MU   63.43 (-0.81%)
AMD   86.71 (+1.93%)
T   28.99 (-0.82%)
NIO   53.69 (+0.34%)
F   9.08 (-3.92%)
ACB   8.71 (-5.63%)
NFLX   485.00 (+0.44%)
GILD   59.50 (-1.24%)
BA   217.61 (-0.40%)
DIS   149.09 (-1.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
QQQ   296.28 (+0.61%)
AAPL   116.03 (+0.75%)
MSFT   213.87 (+0.00%)
FB   275.59 (-0.48%)
GOOGL   1,764.13 (+0.01%)
AMZN   3,185.07 (+2.15%)
TSLA   574.00 (+3.35%)
NVDA   529.39 (+2.14%)
BABA   277.72 (-0.80%)
CGC   26.87 (-0.37%)
GE   10.50 (+0.48%)
MU   63.43 (-0.81%)
AMD   86.71 (+1.93%)
T   28.99 (-0.82%)
NIO   53.69 (+0.34%)
F   9.08 (-3.92%)
ACB   8.71 (-5.63%)
NFLX   485.00 (+0.44%)
GILD   59.50 (-1.24%)
BA   217.61 (-0.40%)
DIS   149.09 (-1.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
QQQ   296.28 (+0.61%)
AAPL   116.03 (+0.75%)
MSFT   213.87 (+0.00%)
FB   275.59 (-0.48%)
GOOGL   1,764.13 (+0.01%)
AMZN   3,185.07 (+2.15%)
TSLA   574.00 (+3.35%)
NVDA   529.39 (+2.14%)
BABA   277.72 (-0.80%)
CGC   26.87 (-0.37%)
GE   10.50 (+0.48%)
MU   63.43 (-0.81%)
AMD   86.71 (+1.93%)
T   28.99 (-0.82%)
NIO   53.69 (+0.34%)
F   9.08 (-3.92%)
ACB   8.71 (-5.63%)
NFLX   485.00 (+0.44%)
GILD   59.50 (-1.24%)
BA   217.61 (-0.40%)
DIS   149.09 (-1.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
QQQ   296.28 (+0.61%)
AAPL   116.03 (+0.75%)
MSFT   213.87 (+0.00%)
FB   275.59 (-0.48%)
GOOGL   1,764.13 (+0.01%)
AMZN   3,185.07 (+2.15%)
TSLA   574.00 (+3.35%)
NVDA   529.39 (+2.14%)
BABA   277.72 (-0.80%)
CGC   26.87 (-0.37%)
GE   10.50 (+0.48%)
MU   63.43 (-0.81%)
AMD   86.71 (+1.93%)
T   28.99 (-0.82%)
NIO   53.69 (+0.34%)
F   9.08 (-3.92%)
ACB   8.71 (-5.63%)
NFLX   485.00 (+0.44%)
GILD   59.50 (-1.24%)
BA   217.61 (-0.40%)
DIS   149.09 (-1.58%)
Log in
LON:CNA

Centrica plc (CNA.L) Price Target, Predictions & Analyst Ratings

GBX 47.13
+1.79 (+3.95 %)
(As of 11/25/2020 05:08 PM ET)
Add
Compare
Today's Range
45.07
Now: GBX 47.13
47.20
50-Day Range
37.20
MA: GBX 41.09
45.35
52-Week Range
29.10
Now: GBX 47.13
95.32
Volume28.84 million shs
Average Volume34.98 million shs
Market Capitalization£2.75 billion
P/E RatioN/A
Dividend Yield11.93%
BetaN/A

Analyst Ratings

Centrica plc (CNA.L) (LON:CNA) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
13 Wall Street analysts have issued ratings and price targets for Centrica plc (CNA.L) in the last 12 months. Their average twelve-month price target is GBX 60.04 The high price target for CNA is GBX 100 and the low price target for CNA is GBX 30. There are currently 3 sell ratings, 7 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
CNA Consensus Rating: HoldHoldHoldHold
CNA Consensus Rating Score: 2.002.002.002.00
CNA Analyst Ratings: 3 Sell Rating(s)
7 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
7 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
7 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
7 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
CNA Consensus Price Target: GBX 60.04GBX 60.04GBX 60.04GBX 57.87

Centrica plc (CNA.L) (LON:CNA) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Centrica plc (CNA.L) (LON:CNA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
7/28/2020Bank of AmericaUpgradeNeutral
7/28/2020Jefferies Financial GroupReiterated RatingHoldGBX 29 ➝ GBX 60
7/27/2020UBS GroupReiterated RatingNeutralGBX 30 ➝ GBX 50
7/27/2020BarclaysBoost Price TargetOverweightGBX 50 ➝ GBX 60
6/12/2020Credit Suisse GroupReiterated RatingOutperformGBX 70
5/13/2020HSBCBoost Price TargetReduceGBX 28 ➝ GBX 30
4/14/2020The Goldman Sachs GroupLower Price TargetNeutralGBX 47 ➝ GBX 42
4/7/2020Royal Bank of CanadaDowngradeUnderperformGBX 85 ➝ GBX 33
3/27/2020Berenberg BankLower Price TargetHoldGBX 85 ➝ GBX 50
2/4/2020JPMorgan Chase & Co.Reiterated RatingNeutralGBX 75
1/14/2020Kepler Capital MarketsDowngradeReduce
1/9/2020Sanford C. BernsteinBoost Price TargetMarket PerformGBX 80 ➝ GBX 90.40
12/4/2019CitigroupUpgradeBuyGBX 128 ➝ GBX 100
6/7/2019Societe GeneraleInitiated CoverageHoldGBX 95
1/17/2019Morgan StanleyReiterated RatingUnderweightGBX 105
12/10/2018Deutsche Bank AktiengesellschaftLower Price TargetSellGBX 135 ➝ GBX 115
(Data available from 11/25/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 11/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.